DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gore ME, Hackshaw A, Brady WE. et al.
Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC).
J Clin Oncol 2015;
33: 5528-5528
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.